Cardiovascular Effects of New Oral Glucose-Lowering Agents: DPP-4 and SGLT-2 Inhibitors.
published in: Circulation Research
date of publication: 2018-05-01
Cites articles 164
- 2017-08-23
Date
Title
Article - wd:Q55053753